LAURA MURRAY: Open Payments
NPI 1457657397 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,955 in 103 payments from 26 companies in 2025. Trend: 2023 $1,893 · 2024 $2,131 · 2025 $1,955
Food & beverage: $1,955
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $326 |
| PFIZER INC. | 17 | $203 |
| AstraZeneca Pharmaceuticals LP | 6 | $172 |
| Amgen Inc. | 13 | $157 |
| Astellas Pharma US Inc | 5 | $109 |
| ViiV Healthcare Company | 4 | $98 |
| Urgo Medical North America, LLC | 3 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $80 |
| Exact Sciences Corporation | 3 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
Products named: QULIPTA, VRAYLAR, AIRSUPRA, Veozah, PREVNAR 20, APRETUDE, VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP, JARDIANCE.
Industry payments across CO — which companies pay providers there.
